Detalles de la búsqueda
1.
ELISpot assay and prediction of organ transplant rejection.
Int J Immunogenet
; 49(1): 39-45, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34910357
2.
De novo HLA Class II antibodies are associated with the development of chronic but not acute antibody-mediated rejection after liver transplantation - a retrospective study.
Transpl Int
; 33(12): 1799-1806, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33020979
3.
Crossing borders to facilitate live donor kidney transplantation: the Czech-Austrian kidney paired donation program - a retrospective study.
Transpl Int
; 33(10): 1199-1210, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32491249
4.
The possible critical role of T-cell help in DSA-mediated graft loss.
Transpl Int
; 31(6): 577-584, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29405445
5.
Molecular markers of systemic autoimmune disorders: the expression of MHC-located HSP70 genes is significantly associated with autoimmunity development.
Clin Exp Rheumatol
; 35(1): 33-42, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28032847
6.
Novel insights into pretransplant allosensitization in heart transplant recipients in the contemporary era of immunosuppression and rejection surveillance.
Transpl Int
; 29(1): 63-72, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26340387
7.
Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine Booster Doses in Kidney Transplant Recipients: Results of a 12-mo Follow-up From a Prospective Observational Study.
Transplant Direct
; 10(6): e1645, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38769974
8.
Effect of SARS-CoV-2 infection on anti-HLA antibodies and de novo donor specific antibodies incidence in lung transplant recipients.
Transpl Immunol
; 81: 101938, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37865212
9.
Czech-Austrian kidney paired donation: first European cross-border living donor kidney exchange.
Transpl Int
; 30(6): 638-639, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28236641
10.
MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy.
Front Immunol
; 13: 985766, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36189289
11.
Intimal Arteritis and Microvascular Inflammation Are Associated With Inferior Kidney Graft Outcome, Regardless of Donor-Specific Antibodies.
Front Med (Lausanne)
; 8: 781206, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34957155
12.
Predictive Potential of Flow Cytometry Crossmatching in Deceased Donor Kidney Transplant Recipients Subjected to Peritransplant Desensitization.
Front Med (Lausanne)
; 8: 780636, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34970564
13.
Chronic Active Antibody-Mediated Rejection Is Associated With the Upregulation of Interstitial But Not Glomerular Transcripts.
Front Immunol
; 12: 729558, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34616398
14.
A Europe wide acceptable mismatch program will enable transplantation of long waiting highly sensitised patients with a compatible donor.
Transpl Immunol
; 64: 101354, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33276060
15.
Donor specific anti-HLA antibodies and cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis.
Transpl Immunol
; 65: 101340, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33069814
16.
Data and optimisation requirements for Kidney Exchange Programs.
Health Informatics J
; 27(2): 14604582211009918, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33878984
17.
Towards uniformity in the definition of acceptable mismatches for highly sensitized patients.
HLA
; 94(2): 147-153, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31177642
18.
Heterologous Cytomegalovirus and Allo-Reactivity by Shared T Cell Receptor Repertoire in Kidney Transplantation.
Front Immunol
; 10: 2549, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31736968
19.
Antibody-mediated rejection after liver transplantation-relevance of C1q and C3d-binding antibodies.
HLA
; 92 Suppl 2: 34-37, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30054978
20.
Efficacy and safety of BORTEZOMIB treatment for refractory acute antibody-mediated rejection-a pilot study.
HLA
; 92 Suppl 2: 47-50, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30168284